132 related articles for article (PubMed ID: 37473646)
1. Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
Kaur A; Javed MU; Venables B; Murison M; Yarrow J
J Plast Reconstr Aesthet Surg; 2023 Oct; 85():95-97. PubMed ID: 37473646
[No Abstract] [Full Text] [Related]
2. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Bartenjev MS; Isaković-Vidović S; Bartenjev I
Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
[TBL] [Abstract][Full Text] [Related]
3. Periocular lentigo maligna treated with imiquimod.
O'Neill J; Ayers D; Kenealy J
J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
[TBL] [Abstract][Full Text] [Related]
4. Should topical imiquimod be used for positive margins in lentigo maligna?
Wang TS; Griffiths CC; Roman EM
J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
[No Abstract] [Full Text] [Related]
5. Lentigo maligna successfully treated with imiquimod.
du Plessis PJ
S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
[No Abstract] [Full Text] [Related]
6. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
Lallas A; Moscarella E; Kittler H; Longo C; Thomas L; Zalaudek I; Kyrgidis A; Manoli SM; di Meo N; Papageorgiou C; Apalla Z; Argenziano G
Br J Dermatol; 2021 Sep; 185(3):675-677. PubMed ID: 33894006
[No Abstract] [Full Text] [Related]
7. Five-year recurrence rate of lentigo maligna after off-label treatment with imiquimod.
Cliff SH
Br J Dermatol; 2016 Jan; 174(1):22-3. PubMed ID: 26790655
[No Abstract] [Full Text] [Related]
8. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
Powell AM; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
[TBL] [Abstract][Full Text] [Related]
9. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
Australas J Dermatol; 2022 May; 63(2):e198-e199. PubMed ID: 35107826
[No Abstract] [Full Text] [Related]
10. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
11. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Woodmansee CS; McCall MW
Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
[No Abstract] [Full Text] [Related]
12. RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY.
De Giorgi V; Zuccaro B; Silvestri F; Venturi F; Colombo J; Trane L
Exp Oncol; 2023 Jun; 45(1):125-129. PubMed ID: 37417274
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod in the treatment of extensive recurrent lentigo maligna.
Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
[TBL] [Abstract][Full Text] [Related]
14. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
Actas Dermosifiliogr; 2022 Apr; 113(4):407-412. PubMed ID: 35431054
[TBL] [Abstract][Full Text] [Related]
15. Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.
Muir J; McCormack C; De'Ambrosis B; Brown H; Kennedy D; Louie B; Smithers BM
Australas J Dermatol; 2022 May; 63(2):e197-e198. PubMed ID: 35262178
[No Abstract] [Full Text] [Related]
16. Surgical treatments for lentigo maligna: a review.
McLeod M; Choudhary S; Giannakakis G; Nouri K
Dermatol Surg; 2011 Sep; 37(9):1210-28. PubMed ID: 21631635
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
18. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
Actas Dermosifiliogr; 2022 Apr; 113(4):T407-T412. PubMed ID: 35623739
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment.
Kwak R; Joyce C; Werchniak AE; Lin JY; Tsibris HC
J Dermatolog Treat; 2022 Jun; 33(4):1995-1999. PubMed ID: 34315342
[TBL] [Abstract][Full Text] [Related]
20. Remission of extensive lentigo maligna after treatment with imiquimod.
Piazza CD; Sampaio SA
An Bras Dermatol; 2009; 84(1):82-4. PubMed ID: 19377765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
